Ticker	Volume	Price	Price Delta
DJIA	15,294.50	-12.67	-0.08%
S&P 500	1,650.51	-4.84	-0.29%
Nasdaq	3,459.42	-3.88	-0.11%

Ticker

Volume

Price

Price Delta

DJIA

15,294.50

-12.67

-0.08%

S&P 500

1,650.51

-4.84

-0.29%

Nasdaq

3,459.42

-3.88

-0.11%

Ticker	Volume	Price	Price Delta
STOXX 50	2,776.78	-58.23	-2.05%
FTSE 100	6,696.79	-143.48	-2.10%
DAX	8,351.98	-178.91	-2.10%

Ticker

Volume

Price

Price Delta

STOXX 50

2,776.78

-58.23

-2.05%

FTSE 100

6,696.79

-143.48

-2.10%

DAX

8,351.98

-178.91

-2.10%

Ticker	Volume	Price	Price Delta
Nikkei	14,603.20	+119.20	0.82%
Hang Seng	22,624.20	-45.47	-0.20%
S&P/ASX 200	4,962.30	-100.15	-1.98%

Ticker

Volume

Price

Price Delta

Nikkei

14,603.20

+119.20

0.82%

Hang Seng

22,624.20

-45.47

-0.20%

S&P/ASX 200

4,962.30

-100.15

-1.98%

Metabolix Has Record Drop After ADM Ends Bio-Plastics Venture

By Jack Kaskey - 2012-01-13T14:36:35Z

Metabolix Inc. (MBLX), the Massachusetts maker of plant-derived chemicals, had its biggest intraday decline after Archer Daniels Midland Co. (ADM) unexpectedly ended a joint venture that made bio-plastics.

Metabolix, based in Cambridge, dropped 55 percent to $2.68 at 9:33 a.m. in New York, the largest fall since the company began trading in 2006.

The companies’ alliance will end Feb. 8 because its financial returns are “too uncertain,” Decatur, Illinois-based ADM said in a statement yesterday. The company will dissolve Telles LLC, created with Metabolix to sell the bio-plastic Mirel, while retaining an ADM factory in Clinton, Iowa, where the corn-based resin was made.

Metabolix didn’t expect the cancellation and will start evaluating options for commercializing its bio-plastics technology, including searching for a new partner, Chief Executive OfficerRichard Eno said yesterday in a conference call.

To contact the reporter on this story: Jack Kaskey in Houston at jkaskey@bloomberg.net

To contact the editor responsible for this story: Simon Casey at scasey4@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.